Cargando…
Critical Illness Risk and Long-Term Outcomes Following Intensive Care in Pediatric Hematopoietic Cell Transplant Recipients
BACKGROUND: Allogeneic hematopoietic cell transplantation (HCT) can be complicated by the development of organ toxicity and infection necessitating intensive care. Risk factors for intensive care admission are unclear due to heterogeneity across centers, and long-term outcome data after intensive ca...
Autores principales: | Zinter, Matt S., Brazauskas, Ruta, Strom, Joelle, Chen, Stella, Bo-Subait, Stephanie, Sharma, Akshay, Beitinjaneh, Amer, Dimitrova, Dimana, Guilcher, Greg, Preussler, Jaime, Myers, Kasiani, Bhatt, Neel S., Ringden, Olle, Hematti, Peiman, Hayashi, Robert J., Patel, Sagar, De Oliveira, Satiro Nakamura, Rotz, Seth, Badawy, Sherif M., Nishihori, Taiga, Buchbinder, David, Hamilton, Betty, Savani, Bipin, Schoemans, Hélène, Sorror, Mohamed, Winestone, Lena, Duncan, Christine, Phelan, Rachel, Dvorak, Christopher C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418579/ https://www.ncbi.nlm.nih.gov/pubmed/37577706 http://dx.doi.org/10.1101/2023.07.31.23293444 |
Ejemplares similares
-
Unfavorable transcriptome profiles and social disadvantage in hematopoietic cell transplantation: a CIBMTR analysis
por: Taylor, Mallory R., et al.
Publicado: (2023) -
Beyond fludarabine: pentostatin plus cyclophosphamide are a well-tolerated alternative in reduced intensity conditioning
por: Dimitrova, Dimana, et al.
Publicado: (2022) -
Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury–Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant
por: Dandoy, Christopher E., et al.
Publicado: (2020) -
Effects of Oxidative Stress on Mesenchymal Stem Cell Biology
por: Denu, Ryan A., et al.
Publicado: (2016) -
Allogeneic Hematopoietic Cell Transplantation for Patients With Deficiency of Adenosine Deaminase 2 (DADA2): Approaches, Obstacles and Special Considerations
por: Hashem, Hasan, et al.
Publicado: (2022)